Hanmi's Merger Plan Could Spark Power Struggle In South Korea Pharma Sector
OCI Alliance Good For Future Cash Flow?
Executive Summary
An unexpected merger between Korea's Hanmi Pharm Group and chemical group OCI may raise eyebrows in terms of likely synergies, but analysts are viewing the planned transaction positively in terms of future cash flow. However, resistance from some members of Hanmi's founder family may mean a possible leadership struggle at the pharma company.